![Hans-Eckart Radunz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans-Eckart Radunz has been Chief Scientific Officer of NanoDel Technologies GmbH since November 2003.
Prior to founding NanoDel Technologies, he was Head of Research for Merck KGaA. He has 30 years of operational experience in international pharma and chemical management, development and implementation of strategies for pharmaceutical development as well as the development of new businesses.
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK KGAA | Hoofd Techniek/Wetenschap/O&O | - |
NanoDel Technologies GmbH
 NanoDel Technologies GmbH Medical/Nursing ServicesHealth Services Develops therapeutics for the treatment of central nervous system (CNS) related diseases | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
NanoDel Technologies GmbH
NanoDel Technologies GmbH Medical/Nursing ServicesHealth Services Develops therapeutics for the treatment of central nervous system (CNS) related diseases | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
